NCT03389893 Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis Status TERMINATED Phase PHASE4
NCT03387852 Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants Status COMPLETED Phase PHASE2
NCT03387657 A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide Status COMPLETED Phase PHASE1
NCT03386344 Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control Status TERMINATED Phase PHASE3
NCT03379558 Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study Status TERMINATED Phase N/A
NCT03376802 A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese Subjects Status COMPLETED Phase PHASE1
NCT03375047 Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT03367819 Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT03359837 Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy Status COMPLETED Phase PHASE4
NCT03359356 Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT03353350 Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise Status COMPLETED Phase PHASE3
NCT03351478 Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin Status COMPLETED Phase PHASE3
NCT03350191 A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients Status COMPLETED Phase PHASE1
NCT03346434 Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) Status COMPLETED Phase PHASE2/PHASE3
NCT03345914 Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3
NCT03344029 Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years Status COMPLETED Phase PHASE4